Literature DB >> 15221114

[Invasive cardiac catheter procedure for thromboembolic pulmonary hypertension].

B Hennen1.   

Abstract

The hemodynamic assessment and angiographic visualization of the pulmonary artery system are the mayor components for the diagnostic and therapeutical planning for patients with known or suspected pulmonary hypertension due to chronic thromboembolism. The pulmonary artery pressure and the pulmonary arterial resistance both reflect the severity of the disease. Pulmonary wave form analysis allows to some degree an etiologic differentiation of pulmonary hypertension. The typical angiographic findings of central pulmonary embolism are best identified by biplane side and lobe selected angiography of the arterial and venous phase with simultaneous consideration of the overall contrast medium exposure. Typical occasional coronary findings are residues of coronary embolism in patients with patent foramen ovale and excentric compression of the left main stem probably due to dilatation of the pulmonary artery.

Entities:  

Mesh:

Year:  2004        PMID: 15221114     DOI: 10.1007/s00101-004-0714-0

Source DB:  PubMed          Journal:  Anaesthesist        ISSN: 0003-2417            Impact factor:   1.041


  3 in total

1.  Images in cardiovascular medicine. Left main coronary artery compression by the pulmonary trunk in pulmonary hypertension.

Authors:  Diana Bonderman; Dominik Fleischmann; Mathias Prokop; Walter Klepetko; Irene M Lang
Journal:  Circulation       Date:  2002-01-15       Impact factor: 29.690

2.  Pulmonary artery pulse pressure and wave reflection in chronic pulmonary thromboembolism and primary pulmonary hypertension.

Authors:  V Castelain; P Hervé; Y Lecarpentier; P Duroux; G Simonneau; D Chemla
Journal:  J Am Coll Cardiol       Date:  2001-03-15       Impact factor: 24.094

3.  Pulmonary artery reflection for differentially diagnosing primary pulmonary hypertension and chronic pulmonary thromboembolism.

Authors:  Y Nakayama; N Nakanishi; T Hayashi; N Nagaya; F Sakamaki; N Satoh; H Ohya; S Kyotani
Journal:  J Am Coll Cardiol       Date:  2001-07       Impact factor: 24.094

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.